Two coronavirus vaccines begin the last phase of testing: 30,000-person trials
The first participants received shots in a 30,000-person trial of an experimental vaccine being developed by biotech company Moderna in partnership with the U.S. government.
View original article
Contributor: Carolyn Y. Johnson
